Cochrane · systematic review · CD007126

Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain

McNicol, ED, Ferguson, MC, Haroutounian, S, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
34
current version
GRADE rated
34
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 16 · 47.1%Low 11 · 32.4%Moderate 6 · 17.6%High 1 · 2.9%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Proportion of participants experiencing at least 50% of maximum pain relief at 4 hours

Population: patients with postoperative pain
7 questions
OutcomeEffectEvidenceStatus / GRADE
Para/propacetamol vs placebo see footnote1
RR 2.53 [2.01, 3.19]11 studies · 1149 participantsHigh
Paracetamol vs placebo see footnote1
RR 4.8 [2.3, 10]5 studies · 393 participantsModerate
Downgraded: inconsistency
Propacetamol vs placebo see footnote1
RR 2.19 [1.74, 2.77]8 studies · 756 participantsModerate
Downgraded: inconsistency
Para/propacetamol vs NSAIDs see footnote1
RR 1.01 [0.86, 1.18]5 studies · 353 participantsLow
Paracetamol vs NSAIDs see footnote1
RR 0.9 [0.72, 1.13]2 studies · 130 participantsVery low
Downgraded: imprecision
Propacetamol vs NSAIDs see footnote1
RR 1.08 [0.86, 1.34]3 studies · 223 participantsVery low
Downgraded: imprecision, inconsistency
Paracetamol vs propacetamol see footnote1
RR 0.98 [0.77, 1.24]3 studies · 361 participantsModerate

Proportion of participants experiencing at least 50% of maximum pain relief at 6 hours

Population: patients with postoperative pain
7 questions
OutcomeEffectEvidenceStatus / GRADE
Para/propacetamol vs placebo see footnote1
RR 2.86 [2.1, 3.91]10 studies · 1143 participantsModerate
Downgraded: inconsistency
Paracetamol vs placebo see footnote1
RR 3.65 [2.15, 6.21]6 studies · 532 participantsModerate
Downgraded: inconsistency
Propacetamol vs placebo see footnote1
RR 2.4 [1.64, 3.5]6 studies · 611 participantsLow
Downgraded: imprecision, inconsistency, publication bias
Para/propacetamol vs NSAIDs see footnote1
RR 0.79 [0.66, 0.95]5 studies · 355 participantsVery low
Downgraded: publication bias
Paracetamol vs NSAIDs see footnote1
RR 0.82 [0.66, 1.02]3 studies · 212 participantsVery low
Downgraded: imprecision
Propacetamol vs NSAIDs see footnote1
RR 0.75 [0.56, 1.02]2 studies · 143 participantsVery low
Downgraded: imprecision
Paracetamol vs propacetamol see footnote1
RR 0.94 [0.73, 1.2]3 studies · 361 participantsLow
Downgraded: imprecision

Mean pain intensity over a 4‐hour period

Population: patients with postoperative pain
2 questions
OutcomeEffectEvidenceStatus / GRADE
Paracetamol vs placebo
no estimate extracted6 studies · 485 participantsLow
Downgraded: risk of bias, imprecision
Paracetamol vs NSAIDs
no estimate extracted6 studies · 350 participantsVery low
Downgraded: risk of bias, inconsistency

Mean pain intensity over a 6‐hour period

Population: patients with postoperative pain
2 questions
OutcomeEffectEvidenceStatus / GRADE
Paracetamol vs placebo
no estimate extracted12 studies · 837 participantsLow
Downgraded: inconsistency
Paracetamol vs NSAIDs
no estimate extracted9 studies · 524 participantsVery low
Downgraded: risk of bias, inconsistency

Proportion of participants receiving additional analgesic medication

Population: patients with postoperative pain
7 questions
OutcomeEffectEvidenceStatus / GRADE
Para/propacetamol vs placebo
RR 0.7 [0.64, 0.77]9 studies · 859 participantsLow
Downgraded: risk of bias, inconsistency
Paracetamol vs placebo
RR 0.75 [0.69, 0.82]6 studies · 655 participantsLow
Downgraded: risk of bias, inconsistency
Propacetamol vs placebo
RR 0.49 [0.35, 0.69]3 studies · 204 participantsLow
Downgraded: risk of bias, inconsistency
Para/propacetamol vs NSAIDs
RR 1.19 [0.87, 1.63]5 studies · 309 participantsVery low
Downgraded: risk of bias, imprecision
Paracetamol vs NSAIDs
RR 1.08 [0.59, 1.98]2 studies · 120 participantsVery low
Downgraded: risk of bias, imprecision
Propacetamol vs NSAIDs
RR 1.23 [0.86, 1.77]3 studies · 189 participantsVery low
Downgraded: risk of bias, imprecision
Propacetamol vs opioids
RR 1.83 [0.72, 4.64]2 studies · 139 participantsVery low
Downgraded: risk of bias, imprecision

Opioid consumption (IV morphine equivalents) over 6 hours

Population: patients with postoperative pain
6 questions
OutcomeEffectEvidenceStatus / GRADE
Para/propacetamol vs placebo see footnote1
no estimate extracted13 studies · 777 participantsModerate
Downgraded: risk of bias
Paracetamol vs placebo see footnote1
no estimate extracted8 studies · 404 participantsLow
Downgraded: risk of bias, inconsistency
Propacetamol vs placebo see footnote1
no estimate extracted6 studies · 373 participantsLow
Downgraded: risk of bias, inconsistency
Para/propacetamol vs NSAIDs see footnote1
no estimate extracted8 studies · 540 participantsVery low
Downgraded: risk of bias
Paracetamol vs NSAIDs see footnote1
no estimate extracted3 studies · 160 participantsVery low
Downgraded: imprecision
Propacetamol vs NSAIDs see footnote1
no estimate extracted5 studies · 380 participantsVery low
Downgraded: imprecision

Proportion of participants vomiting

Population: patients with postoperative pain
3 questions
OutcomeEffectEvidenceStatus / GRADE
Para/propacetamol vs placebo
RR 0.7 [0.57, 0.87]15 studies · 1414 participantsVery low
Downgraded: inconsistency, publication bias
Paracetamol vs placebo
RR 0.64 [0.51, 0.8]13 studies · 1037 participantsVery low
Downgraded: publication bias
Propacetamol vs placebo
RR 1.62 [0.75, 3.48]3 studies · 377 participantsLow
Downgraded: imprecision